DiaCarta Inc. Receives CE Mark for QuantiVirus

Hayward, CA (PRWEB) March 15, 2013

DiaCarta Inc., an in vitro diagnostic company for infectious diseases, cancer and other indications, today announced it has received CE Mark approval for its QuantiVirus

This entry was posted in Biotechnology and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply